Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

Ensayo clínico

The Evaluation of Safety and Myopia Progression Control Using Novel Spectacle Lens

NCT: NCT05886348 · ACTIVE_NOT_RECRUITING

ID NCTNCT05886348
EstadoACTIVE_NOT_RECRUITING
Fecha de inicio2023-07-31
Finalización2027-05-31
SponsorHOYA Lens Thailand LTD. (INDUSTRY)
First posted
Last updated

Resumen breve

The goal of this clinical trial is to test Novel spectacle lenses in myopic children. The main question it aims to answer are: safety and efficacy of the lenses. Participants will be asked to wear spectacles and participate in eye exams and questionnaires. Researchers will compare Novel spectacle lenses and general single vision spectacle lenses to see if the Novel spectacle lenses correct myopic ametropia, slow the progression of myopia and axial elongation.

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.

↑